Quotient Clinical reports another successful year of record growth
7 May 2015 | By kdm communications
Operating capacity set to more than double in response to rising demand...
List view / Grid view
News
Bill & Melinda Gates Foundation to fund CHAMPS – a network of disease surveillance sites
7 May 2015 | By Victoria White
The Bill & Melinda Gates Foundation are set to announce CHAMPS - a network of disease surveillance sites in developing countries...
Johnson & Johnson announces groundbreaking partnership to evaluate compassionate use requests of investigational medicines
7 May 2015 | By Victoria White
J&J has announced a first-of-its-kind partnership that enlists a third party to review compassionate use requests made for investigational medicines...
Alexion to acquire Synageva in $8.4 billion deal
7 May 2015 | By Victoria White
Alexion Pharmaceuticals has announced that it is set to acquire Synageva BioPharma in a transaction valued at approximately $8.4 billion...
FDA grants Breakthrough Therapy Designation for venetoclax in 17p deletion relapsed-refractory chronic lymphocytic leukaemia
7 May 2015 | By Victoria White
The FDA has granted Breakthrough Therapy Designation for venetoclax for the treatment of people who have relapsed or refractory CLL with 17p deletion...
Nulojix regimen beats cyclosporine in 7-year trial in kidney transplant patients
7 May 2015 | By
A 7-year study of a Nulojix regimen has demonstrated a significant relative risk reduction of death or transplant failure over a cyclosporine regimen...
Alzheimer’s disease treatment market value will exceed $13 billion by 2023, says GlobalData
7 May 2015 | By Victoria White
The global market for Alzheimer’s disease treatment will more than double in value from $4.9 billion in 2013 to reach an estimated $13.3 billion by 2023...
GSK, Telethon and OSR announce EU regulatory submission for gene therapy to treat rare disease ADA-SCID
6 May 2015 | By Victoria White
GSK, Telethon and OSR have submitted a marketing application to the EMA for a gene therapy to treat patients with a rare disease, ADA-SCID...
Teva completes acquisition of Auspex; continues pursuit of Mylan
6 May 2015 | By Victoria White
Teva has acquired Auspex Pharmaceuticals through the successful tender offer for all of the outstanding Auspex shares at $101.00 per share...
Lilly reveals plan for Innovation Centre in Cambridge, MA
6 May 2015 | By Victoria White
Lilly is set to establish a new drug delivery and device innovation centre in Cambridge, increasing its delivery and devise R&D space by almost 50%...
Positive top-line results from Phase 3 trial of RBP-7000 in schizophrenia announced
6 May 2015 | By Victoria White
Indivior has announced top-line results from its Phase 3 clinical trial of RBP-7000, an investigational drug for the treatment of schizophrenia...
Positive results from Phase 2 study of APD403 in chemotherapy-induced nausea & vomiting
6 May 2015 | By
Acacia Pharma has announced positive results from its Phase 2 study of APD403 in the prevention of chemotherapy-induced nausea & vomiting (CINV)...
New NDA Infographic highlights state of drug approvals in 2014: EU vs USA
6 May 2015 | By Victoria White
NDA Group's new Infographic looks at drug approvals in 2014 and highlights the fact that nearly 40% of approved products came from non top pharma companies...
Handheld device identifies pressure ulcers early and saves hospitals £50,000 per month
6 May 2015 | By Victoria White
A handheld device that identifies pressure ulcers in the earliest stage of their development has saved two UK NHS hospitals £50,000 per month during trials...
Cardio3 BioSciences announces results of annual shareholder assembly 2015; confirms name change to Celyad
6 May 2015 | By Victoria White
All resolutions presented at Cardio3 BioSciences' Annual Shareholder Assembly were duly passed including a name change for the Company to Celyad...
